Top

Published in:

01-12-2023 | Research

Investigations on melamine-based uric acid kidney stone formation and its prevention by inhibitors

Authors: Ashish P. Pradhane, Ravi N. Methekar, Shailesh G. Agrawal

Published in: Urolithiasis | Issue 1/2023

Abstract

Melamine (Mel) as a milk powder adulterant came to light in September 2008, when a kidney stone disease (KSD) outbreak struck China. The mechanism of the formation of Mel-associated uric acid (UA) stones is relatively unknown. Therefore, in the present study, Mel's influence was explored at comparatively higher and lower concentrations in artificial urine. The parameter optimization performed when the Mel concentration in artificial urine was low, which revealed that higher pH values and lower UA concentration considerably delayed the induction of UA crystallization. When Mel concentration was increased relative to UA concentration, the induction time of UA crystallization decreased dramatically. At the highest concentration of Mel investigated (at UA–Mel molar ratio 1:1), PXRD analysis and SEM revealed a change in crystalline structure of the samples. Based on FTIR analysis, it was determined that UA–Mel interactions are essentially physical, because no new characteristic bands developed. Two inhibitors, namely tri-potassium citrate (TPC) and 3, 7-dimethylxanthine (DMX), were investigated for their inhibitory action on UA crystallization in the presence of Mel. DMX was observed to be more promising than TPC in delaying the induction of crystallisation and hence inhibiting crystal formation.

Available only for authorised users

Ngo TC, Assimos DG (2007) Uric acid nephrolithiasis: recent progress and future directions. Rev Urol 9:17–27PubMedPubMedCentral

Costa-Bauza A, Grases F, Calvó P et al (2018) Effect of consumption of cocoa-derived products on uric acid crystallization in urine of healthy volunteers. Nutrients. https://doi.org/10.3390/nu10101516CrossRefPubMedPubMedCentral

Brikowski TH, Lotan Y, Pearle MS (2008) Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci U S A 105:9841–9846. https://doi.org/10.1073/pnas.0709652105CrossRefPubMedPubMedCentral

Kesavan M, Kaliaperumal R, Tamilmani E, Shanmugam K (2012) In vitro evaluation of calcium oxalate monohydrate crystals influenced by costus igneus aqueous extract. Scand J Urol Nephrol 46:290–297. https://doi.org/10.3109/00365599.2012.669792CrossRefPubMed

Indridason OS, Birgisson S, Edvardsson VO et al (2006) Epidemiology of kidney stones in Iceland: a population-based study. Scand J Urol Nephrol 40:215–220. https://doi.org/10.1080/00365590600589898CrossRefPubMed

Dong W, Zhang Y, Hu P et al (2019) Rate-controlled nano-layered assembly mechanism of melamine-induced melamine-uric acid stones and its inhibition and elimination methods. J Mater Chem B 7:4133–4140. https://doi.org/10.1039/c9tb00688eCrossRef

Li G, Jiao S, Yin X et al (2010) The risk of melamine-induced nephrolithiasis in young children starts at a lower intake level than recommended by the WHO. Pediatr Nephrol 25:135–141. https://doi.org/10.1007/s00467-009-1298-3CrossRefPubMed

Poon NW, Gohel MDI, Lau C et al (2012) Melamine crystallization: physicochemical properties, interactions with other lithogenic salts and response to therapeutic agents. J Urol 187:1483–1490. https://doi.org/10.1016/j.juro.2011.11.078CrossRefPubMed

Brown CA, Jeong K-S, Poppenga RH et al (2007) Outbreaks of renal failure associated with melamine and cyanuric acid in dogs and cats in 2004 and 2007. J Vet Diagn Investig 19:525–531. https://doi.org/10.1177/104063870701900510CrossRef

10.

Hau AKC, Kwan TH, Li PKT (2009) Melamine toxicity and the kidney. J Am Soc Nephrol 20:245–250. https://doi.org/10.1681/ASN.2008101065CrossRefPubMed

11.

Takagi K, Fujii K, Yamazaki KI et al (2012) Biodegradation of melamine and its hydroxy derivatives by a bacterial consortium containing a novel nocardioides species. Appl Microbiol Biotechnol 94:1647–1656. https://doi.org/10.1007/s00253-011-3673-9CrossRefPubMed

12.

Dong W, Wu Q (2019) Dual roles of melamine in the formation of calcium oxalate stones. Cryst Growth Des 19:3998–4007. https://doi.org/10.1021/acs.cgd.9b00389CrossRef

13.

Rai N, Banerjee D, Bhattacharyya R (2014) Urinary melamine: proposed parameter of melamine adulteration of food. Nutrition 30:380–385. https://doi.org/10.1016/j.nut.2013.07.013CrossRefPubMed

14.

Liu G, Li S, Jia J et al (2010) Pharmacokinetic study of melamine in rhesus monkey after a single oral administration of a tolerable daily intake dose. Regul Toxicol Pharmacol 56:193–196. https://doi.org/10.1016/j.yrtph.2009.09.014CrossRefPubMed

15.

Melnick RL, Boorman GA, Haseman JK et al (1984) Urolithiasis and bladder carcinogenicity of melamine in rodents. Toxicol Appl Pharmacol 72:292–303. https://doi.org/10.1016/0041-008X(84)90314-4CrossRefPubMed

16.

Clark R (1966) Melamine crystalluria in sheep. J S Afr Vet Assoc 37:349–351

17.

Sharma K, Paradkar M (2010) The melamine adulteration scandal. Food Secur 2:97–107. https://doi.org/10.1007/s12571-009-0048-5CrossRef

18.

Sun Q, Shen Y, Sun N et al (2010) Diagnosis, treatment and follow-up of 25 patients with melamine-induced kidney stones complicated by acute obstructive renal failure in Beijing Children’s Hospital. Eur J Pediatr 169:483–489. https://doi.org/10.1007/s00431-009-1093-yCrossRefPubMed

19.

Stapleton FB, Linshaw MA, Hassanein K, Gruskin AB (1978) Uric acid excretion in normal children. J Pediatr 92:911–914. https://doi.org/10.1016/S0022-3476(78)80359-XCrossRefPubMed

20.

Dong W, Hu R, Wu Q (2019) A new discovery of calcium phosphate urinary stones formation induced by melamine: nanocrystalline assembly mechanism. Chinese J Chem 37:700–708. https://doi.org/10.1002/cjoc.201900124CrossRef

21.

Giroto AS, Garcia RHS, Colnago LA et al (2020) Role of urea and melamine as synergic co-plasticizers for starch composites for fertilizer application. Int J Biol Macromol 144:143–150. https://doi.org/10.1016/j.ijbiomac.2019.12.094CrossRefPubMed

22.

Zheng T, Pilla S (2018) Encapsulation of hydrophilic payload by PU-PMF capsule: Effect of melamine-formaldehyde pre-polymer content, pH and temperature on capsule morphology. Coll Surf Physicochem Eng Asp 542:59–67. https://doi.org/10.1016/j.colsurfa.2018.01.040CrossRef

23.

Shellaiah M, Sun KW (2019) Review on nanomaterial-based melamine detection. Chemosensors 7:1–47. https://doi.org/10.3390/CHEMOSENSORS7010009CrossRef

24.

Königsberger E, Wang Z (1999) Solubility of uric acid in salt solutions and artificial urine. Monatshefte fur Chemie 130:1067–1073. https://doi.org/10.1007/PL00010284CrossRef

25.

Pradhane AP, Methekar RN, Agrawal SG (2022) Batch Crystallization of Uric Acid: Modeling, Simulation, and the Impact of 3, 7–dimethylxanthine. Cryst Res Technol 2200125

26.

Gossner CME, Schlundt J, Ben EP et al (2009) The melamine incident: Implications for international food and feed safety. Environ Health Perspect 117:1803–1808. https://doi.org/10.1289/ehp.0900949CrossRefPubMedPubMedCentral

27.

Grases F, Ramis M, Villacampa AI, Costa-Bauzá A (1999) Uric acid urolithiasis and crystallization inhibitors. Urol Int 62:201–204CrossRefPubMed

28.

Grases F, Rodriguez A, Costa-Bauza A (2014) Theobromine inhibits uric acid crystallization a potential application in the treatment of uric acid nephrolithiasis. PLoS ONE. https://doi.org/10.1371/journal.pone.0111184CrossRefPubMedPubMedCentral

29.

Machado TC, Kuminek G, Cardoso SG, Rodríguez-Hornedo N (2020) The role of pH and dose/solubility ratio on cocrystal dissolution, drug supersaturation and precipitation. Eur J Pharm Sci. https://doi.org/10.1016/j.ejps.2020.105422CrossRefPubMed

30.

Pawar N, Agrawal S, Methekar R (2018) Modeling, simulation, and influence of operational parameters on crystal size and morphology in semibatch antisolvent crystallization of α-lactose monohydrate. Cryst Growth Des 18:4511–4521. https://doi.org/10.1021/acs.cgd.8b00499CrossRef

31.

Sádovská G, Honcová P, Sádovsky Z (2013) Kinetics and enthalpy of crystallization of uric acid dihydrate. Thermochim Acta 566:211–213. https://doi.org/10.1016/j.tca.2013.06.005CrossRef

32.

Brandel C, ter Horst JH (2015) Measuring induction times and crystal nucleation rates. Faraday Discuss 179:199–214. https://doi.org/10.1039/C4FD00230JCrossRefPubMed

33.

Spettel S, Shah P, Sekhar K et al (2013) Using hounsfield unit measurement and urine parameters to predict uric acid stones. Urology 82:22–26. https://doi.org/10.1016/j.urology.2013.01.015CrossRefPubMed

34.

Cameron MA, Maalouf NM, Adams-Huet B et al (2006) Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 17:1422–1428. https://doi.org/10.1681/ASN.2005121246CrossRefPubMed

35.

Han H, Segal AM, Seifter JL, Dwyer JT (2015) Nutritional management of kidney stones (Nephrolithiasis). Clin Nutr Res 4:137. https://doi.org/10.7762/cnr.2015.4.3.137CrossRefPubMedPubMedCentral

36.

Hernandez Y, Costa-Bauza A, Calvó P et al (2020) Comparison of two dietary supplements for treatment of uric acid renal lithiasis citrate vs Citrate Theobromine. Nutrients 12:2012CrossRefPubMedPubMedCentral

37.

Chattaraj KG, Paul S (2019) Inclusion of theobromine modifies uric acid aggregation with possible changes in melamine-uric acid clusters responsible for kidney stones. J Phys Chem B 123:10483–10504. https://doi.org/10.1021/acs.jpcb.9b08487CrossRefPubMed

38.

Chang H, Shi X, Shen W et al (2012) Characterization of melamine-associated urinary stones in children with consumption of melamine-contaminated infant formula. Clin Chim Acta 413:985–991. https://doi.org/10.1016/j.cca.2012.02.025CrossRefPubMed

39.

Sun X, Shen L, Cong X et al (2011) Infrared spectroscopic analysis of urinary stones (including stones induced by melamine-contaminated milk powder) in 189 Chinese children. J Pediatr Surg 46:723–728. https://doi.org/10.1016/j.jpedsurg.2010.09.013CrossRefPubMed

40.

Ringertz H (1966) The molecular and crystal structure of uric acid. Acta Crystallogr 20:397–403. https://doi.org/10.1107/s0365110x66000914CrossRef

41.

Islam MR, Chakraborty AK, Gafur MA et al (2019) Easy preparation of recyclable thermally stable visible-light-active graphitic-C 3 N 4 /TiO 2 nanocomposite photocatalyst for efficient decomposition of hazardous organic industrial pollutants in aqueous medium. Res Chem Intermed 45:1753–1773. https://doi.org/10.1007/s11164-018-3703-7CrossRef

42.

Fu M, Liao J, Dong F et al (2014) Growth of g-C₃N₄ layer on commercial TiO₂ for enhanced visible light photocatalytic activity. J Nanomater 2014:869094CrossRef

43.

Li ZQ, Lu CJ, Xia ZP et al (2007) X-ray diffraction patterns of graphite and turbostratic carbon. Carbon N Y 45:1686–1695. https://doi.org/10.1016/j.carbon.2007.03.038CrossRef

44.

Mongkolsuttirat K, Buajarern J (2021) Uncertainty evaluation of crystallite size measurements of nanoparticle using X-Ray diffraction analysis (XRD). J Phys Conf Ser. https://doi.org/10.1088/1742-6596/1719/1/012054CrossRef

45.

Zhang X, Chen T, Chen Q et al (2009) Self-assembly and aggregation of melamine and melamine-uric/cyanuric acid investigated by STM and AFM on solid surfaces. Phys Chem Chem Phys 11:7708–7712. https://doi.org/10.1039/b907557gCrossRefPubMed

Title: Investigations on melamine-based uric acid kidney stone formation and its prevention by inhibitors
Authors: Ashish P. Pradhane
Ravi N. Methekar
Shailesh G. Agrawal
Publication date: 01-12-2023
Publisher: Springer Berlin Heidelberg
Published in: Urolithiasis / Issue 1/2023
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI: https://doi.org/10.1007/s00240-023-01437-3

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Investigations on melamine-based uric acid kidney stone formation and its prevention by inhibitors

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2023

Metabolic stone workup abnormalities are not as important as stone culture in patients with recurrent stones undergoing percutaneous nephrolithotomy

Prospective comparison of extracorporeal shock wave lithotripsy versus flexible ureterorenoscopy in patients with non–lower pole kidney stones under the COVID-19 pandemic

Asymptomatic bacteriuria in candidates for active treatment of renal stones: results from an international multicentric study on more than 2600 patients

Correction to: Conflicts of interest and the risk of bias are inevitable in urolithiasis research

Healthcare utilization, quality of life, and work productivity associated with primary hyperoxaluria: a cross-sectional web-based US survey

Development and external validation of a machine learning-based model to classify uric acid stones in patients with kidney stones of Hounsfield units < 800